Communications Biology (Feb 2021)
Biocompatible nucleus-targeted graphene quantum dots for selective killing of cancer cells via DNA damage
Abstract
Qi et al. develop nucleus targeting graphene quantum dots (GQDs) by modifying amine-functionalised GQDs with nucleus targeting TAT peptides. The resulting functionalised GQDs exhibit good biocompatibility, nucleus uptake, and cancer cell targeting. They can suppress growth of cancer cells by selectively inducing DNA damage.